Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study

Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study

David Lang,1,2 Wolfgang Haslinger,2 Kaveh Akbari,2,3 Mario Scala,2,3 Benedikt Hergan,2,3 Christian Asel,2,3 Andreas Horner,1,2 Romana Wass,1,2 Elmar Brehm,1,2 Bernhard Kaiser,1 Bernd Lamprecht1,2 1Johannes Kepler University Hospital, Department of Pulmonology, Linz, Austria; 2Johannes Kepler Univers...

Full description

Saved in:
Bibliographic Details
Main Authors: Lang D, Haslinger W, Akbari K, Scala M, Hergan B, Asel C, Horner A, Wass R, Brehm E, Kaiser B, Lamprecht B
Format: article
Language:EN
Published: Dove Medical Press 2020
Subjects:
carcinoembryonic antigen
platinum doublet chemotherapy
pembrolizumab
cyfra 21-1
recist
nivolumab
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Online Access:https://doaj.org/article/de62df45ecee46c7bf7642e198ce9c9e
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/de62df45ecee46c7bf7642e198ce9c9e

Similar Items